Subscribe To

Price Alert Latest News Economic Calendar News

RDNT / 4 Promising Stocks From a Challenging Outpatient Home Health Industry

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects. Read More

Demo Live Account See Partner Details

Content Topics

Promising

Stocks

From

Challenging

Outpatient

Home

Health

Industry

Stock

RDNT

Posted: Mar 23 2023, 12:13

Author Name: Zacks Investment Research

RDNT News

By Seeking Alpha
October 4, 2023

RadNet Stock: Bullish With Several Growth Tailwinds For Diagnostic Imaging

RadNet is capturing a strong demand for diagnostic imaging which benefits from several secular growth trends. The approval of new Alzheimer's drugs re

By GlobeNewsWire
September 20, 2023

RadNet, Inc. to Present at the Sidoti & Company Fall 2023 Virtual Conference on Wednesday, September 20th

LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic im

By Zacks Investment Research
August 8, 2023

RadNet (RDNT) Q2 Earnings and Revenues Top Estimates

RadNet (RDNT) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings

By GlobeNewsWire
July 21, 2023

RadNet, Inc. Announces Date of its Second Quarter 2023 Financial Results Conference Call

LOS ANGELES, July 21, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic ima

By Seeking Alpha
July 17, 2023

RadNet: Growing Procedure Volumes - Significant Upside Potential

RadNet has seen a 13.5% increase in capital appreciation due to growing procedure volumes and overall profitability, with the position up 50.6% since

By GlobeNewsWire
June 5, 2023

RadNet, Inc. to Present at the Jefferies 2023 Global Healthcare Conference on June 8, 2023

LOS ANGELES, June 05, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic ima

By Seeking Alpha
May 13, 2023

RadNet, Inc. (RDNT) Q1 2023 Earnings Call Transcript

RadNet, Inc. (NASDAQ:RDNT ) Q1 2023 Earnings Conference Call May 9, 2023 10:30 AM ET Company Participants Howard Berger - Chairman, President & CEO Ma

By Zacks Investment Research
May 9, 2023

RadNet (RDNT) Reports Q1 Loss, Tops Revenue Estimates

RadNet (RDNT) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.15

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.